Twist Bioscience Corp financial data

Symbol
TWST on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
681 Gateway Blvd., South San Francisco, CA
State of incorporation
DE
Fiscal year end
September 30
Latest financial report
10-Q - Q4 2024 - Feb 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 506 % -18%
Quick Ratio 37.8 % -23.1%
Debt-to-equity 29.5 % +26.9%
Return On Equity -39.9 % -24.7%
Return On Assets -30.8 % -18.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.7M shares +3.17%
Common Stock, Shares, Outstanding 59.6M shares +3.12%
Entity Public Float 1.92B USD +130%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 59.2M shares +2.9%
Weighted Average Number of Shares Outstanding, Diluted 59.2M shares +2.9%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 183M USD +8.6%
Research and Development Expense 89.1M USD -9.81%
Costs and Expenses 539M USD +11.8%
Operating Income (Loss) -208M USD +5.02%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -197M USD +3.83%
Income Tax Expense (Benefit) 537K USD -55.1%
Net Income (Loss) Attributable to Parent -197M USD +4.13%
Earnings Per Share, Basic -3.38 USD/shares +6.37%
Earnings Per Share, Diluted -3.38 USD/shares +6.37%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 221M USD -16.9%
Cash, Cash Equivalents, and Short-term Investments 289M USD -19.8%
Accounts Receivable, after Allowance for Credit Loss, Current 39.3M USD +11.2%
Inventory, Net 23.5M USD -23.8%
Assets, Current 345M USD -11.5%
Property, Plant and Equipment, Net 101M USD -20.2%
Operating Lease, Right-of-Use Asset 56.5M USD -18.3%
Goodwill 85.8M USD 0%
Other Assets, Noncurrent 3.45M USD -36.4%
Assets 609M USD -17%
Accounts Payable, Current 7.5M USD -18.9%
Employee-related Liabilities, Current 21.7M USD +4.59%
Accrued Liabilities, Current 20.1M USD +44.2%
Liabilities, Current 69.6M USD +6.77%
Operating Lease, Liability, Noncurrent 67.6M USD -12.3%
Other Liabilities, Noncurrent 407K USD -14.3%
Liabilities 153M USD +6.91%
Accumulated Other Comprehensive Income (Loss), Net of Tax -649K USD -14.9%
Retained Earnings (Accumulated Deficit) -1.27B USD -18.3%
Stockholders' Equity Attributable to Parent 456M USD -22.7%
Liabilities and Equity 609M USD -17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.4M USD +6.73%
Net Cash Provided by (Used in) Financing Activities 17.9M USD
Net Cash Provided by (Used in) Investing Activities -1.54M USD -137%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 59.6M shares +3.12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.07M USD +74.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 224M USD -16.7%
Deferred Tax Assets, Valuation Allowance 361M USD +19.3%
Deferred Tax Assets, Gross 379M USD +13.3%
Operating Lease, Liability 82.6M USD -10.1%
Depreciation 26.5M USD -2.21%
Payments to Acquire Property, Plant, and Equipment 2.27M USD +50.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -197M USD +2.9%
Lessee, Operating Lease, Liability, to be Paid 130M USD -10.3%
Property, Plant and Equipment, Gross 182M USD -0.97%
Operating Lease, Liability, Current 15M USD +1.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.37M USD -39.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.9M USD -6.96%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47.3M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.47M USD +1.2%
Deferred Tax Assets, Operating Loss Carryforwards 227M USD +8.42%
Unrecognized Tax Benefits 22.4M USD +16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.61M USD -22%
Operating Lease, Payments 14.7M USD +0.02%
Additional Paid in Capital 1.73B USD +3.8%
Amortization of Intangible Assets 3.1M USD -40.4%
Depreciation, Depletion and Amortization 6.38M USD -21.9%
Deferred Tax Assets, Net of Valuation Allowance 18.2M USD -42.8%
Share-based Payment Arrangement, Expense 51.9M USD +19%
Interest Expense 2K USD -92.9%